YD Bio Limited (NASDAQ:YDES) Sees Significant Increase in Short Interest

YD Bio Limited (NASDAQ:YDES) was the recipient of a large growth in short interest in the month of July. As of July 15th, there was short interest totaling 25,094 shares, a growth of 124.7% from the June 30th total of 11,169 shares. Based on an average trading volume of 621,113 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the company’s stock are sold short.

YD Bio Trading Down 1.3%

Shares of YDES traded down $0.03 on Wednesday, reaching $2.27. The stock had a trading volume of 14,620 shares, compared to its average volume of 75,357. The company has a 50-day simple moving average of $2.79 and a 200-day simple moving average of $6.25. YD Bio has a 12-month low of $1.70 and a 12-month high of $25.00.

Hedge Funds Weigh In On YD Bio

An institutional investor recently raised its stake in YD Bio stock. Geode Capital Management LLC lifted its position in YD Bio Limited (NASDAQ:YDES) by 10.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 58,363 shares of the biotechnology company’s stock after buying an additional 5,292 shares during the period. Geode Capital Management LLC owned about 0.08% of YD Bio worth $711,000 as of its most recent SEC filing.

About YD Bio

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.